Metoclopramide HCl

Ingredient matches for Metoclopramide HCl

Metoclopramide

Metoclopramide dihydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Metoclopramide HCl in the following countries:

• United States

International Drug Name Search

Sempera

Sempera may be available in the countries listed below.

Ingredient matches for Sempera

Itraconazole

Itraconazole is reported as an ingredient of Sempera in the following countries:

• Germany

International Drug Name Search

Serelan

Serelan may be available in the countries listed below.

Ingredient matches for Serelan

Mianserin

Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Serelan in the following countries:

• Luxembourg

International Drug Name Search

Bisolex

Bisolex may be available in the countries listed below.

Ingredient matches for Bisolex

Bromhexine

Bromhexine is reported as an ingredient of Bisolex in the following countries:

• Bosnia & Herzegowina


• Croatia (Hrvatska)

International Drug Name Search

Cosy

Cosy may be available in the countries listed below.

Ingredient matches for Cosy

Domperidone

Domperidone is reported as an ingredient of Cosy in the following countries:

• Bangladesh

International Drug Name Search

Ossibiotic

Ossibiotic may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ossibiotic

Oxytetracycline

Oxytetracycline is reported as an ingredient of Ossibiotic in the following countries:

• Italy

International Drug Name Search

Belimumab

Pronunciation: be-LIM-ue-mab
Generic Name: Belimumab
Brand Name: Benlysta

Belimumab is used for:

Treating certain patients with systemic lupus erythematosus (SLE). It may also be used for other conditions as determined by your doctor.

Belimumab is a B-lymphocyte stimulator (BLyS)-specific inhibitor. Patients with lupus often have high levels of a certain protein in their blood. Belimumab works by limiting the activity of that protein.

Do NOT use Belimumab if:

• you are allergic to any ingredient in Belimumab


• you have severe, active central nervous system lupus


• you have certain severe kidney problems associated with lupus (severe, active lupus nephritis)


• you are using another biologic medicine (eg, etanercept, infliximab, immune globulin)


• you are receiving cyclophosphamide as an injection into your vein (intravenous [IV])

Contact your doctor or health care provider right away if any of these apply to you.

Before using Belimumab:

Some medical conditions may interact with Belimumab. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of a long-term infection, an infection that keeps coming back, tuberculosis (TB) infection or a positive TB skin test, or hepatitis B infection


• if you have an infection, open cuts or sores on your body, flu-like symptoms or other signs of infection (eg, fever; chills; cough; warm, red, or painful skin), or are using medicine to treat an infection


• if you have a history of cancer or heart problems


• if you have a history of mental or mood problems (eg, depression), or suicidal thoughts or actions


• if you have recently received a vaccine or are scheduled to receive a vaccine

Some MEDICINES MAY INTERACT with Belimumab. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Other biologic medicines (eg, etanercept, infliximab, immune globulin), IV cyclophosphamide, or monoclonal antibodies (eg, certolizumab, denosumab) because the risk of their side effects may be increased by Belimumab

This may not be a complete list of all interactions that may occur. Ask your health care provider if Belimumab may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Belimumab:

Use Belimumab as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Belimumab comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Belimumab refilled.


• Belimumab is usually given as an injection into the vein at your doctor's office, hospital, or clinic.


• You may receive another medicine before each treatment with Belimumab to decrease the chance of an allergic reaction. Discuss any questions with your doctor.


• Do not use Belimumab if it contains particles, is cloudy or discolored, or if the syringe or pen is cracked or damaged.


• Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.


• If you miss a dose of Belimumab, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Belimumab.

Important safety information:

• Do NOT use more than the recommended dose or use for longer than prescribed without checking with your doctor.


• Belimumab may lower the ability of your body to fight infection and may increase the risk of severe or fatal infection. Avoid contact with people who have colds, flu, shingles, or other infections. Tell your doctor right away if you notice signs of infection like fever, sore throat, rash, or chills.


• Treatment with medicines similar to Belimumab may increase in the risk of developing cancer. It is possible that treatment with Belimumab may also increase this risk. Discuss any questions or concerns with your doctor.


• Some patients using Belimumab reported mental or mood changes (eg, anxiety, depression) and suicidal thoughts or actions. The majority of these patients had a history of depression or other serious mental or mood problems. It is unknown if Belimumab is associated with an increased risk of these events. Tell your doctor right away if you develop anxiety, depression, severe or persistent trouble sleeping, suicidal thoughts or actions, or any other mental or mood changes.


• Tell your doctor or dentist that you take Belimumab before you receive any medical or dental care, emergency care, or surgery.


• Do not receive a live vaccine (eg, measles, mumps) while you are using Belimumab or for 30 days before you begin using it. Talk with your doctor before you receive any vaccine.


• Belimumab may not work as well in black patients. Contact your doctor if your symptoms do not improve or if they become worse.


• Women who may become pregnant should use effective birth control while using Belimumab and for 4 months after the last treatment. Check with your doctor if you have questions about effective birth control.


• Belimumab should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Belimumab while you are pregnant. It is not known if Belimumab is found in breast milk. Do not breast-feed while using Belimumab.

Possible side effects of Belimumab:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; headache; nausea; pain in the arm or leg; sinus inflammation; stomach pain; stuffy or runny nose; trouble sleeping.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; wheezing; unusual hoarseness); fainting; mental or mood changes (eg, anxiety, depression); muscle pain or weakness; severe or persistent headache or dizziness; severe or persistent trouble sleeping; suicidal thoughts or actions; symptoms of heart problems (eg, chest pain or discomfort, shortness of breath, slow heartbeat, dizziness, cold sweats); symptoms of infection (eg, fever, chills, or persistent sore throat; persistent cough; flu-like symptoms; warm, red, or painful skin; open sore that does not heal; increased or painful urination).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Belimumab side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Belimumab:

Belimumab is usually handled and stored by a health care provider. If you are using Belimumab at home, store Belimumab as directed by your pharmacist or health care provider. Keep Belimumab out of the reach of children and away from pets.

General information:

• If you have any questions about Belimumab, please talk with your doctor, pharmacist, or other health care provider.


• Belimumab is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Belimumab. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Belimumab resources

• Belimumab Side Effects (in more detail)
• Belimumab Use in Pregnancy & Breastfeeding
• Belimumab Drug Interactions
• Belimumab Support Group
• 0 Reviews for Belimumab - Add your own review/rating

• Belimumab Professional Patient Advice (Wolters Kluwer)


• belimumab Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information


• Benlysta Prescribing Information (FDA)


• Benlysta Consumer Overview

Compare Belimumab with other medications

• Systemic Lupus Erythematosus

Amitriptilina L.CH.

Amitriptilina L.CH. may be available in the countries listed below.

Ingredient matches for Amitriptilina L.CH.

Amitriptyline

Amitriptyline is reported as an ingredient of Amitriptilina L.CH. in the following countries:

• Chile

International Drug Name Search

Amoxicilina Generifarma

Amoxicilina Generifarma may be available in the countries listed below.

Ingredient matches for Amoxicilina Generifarma

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilina Generifarma in the following countries:

• Spain

International Drug Name Search